HMB (Beta-Hydroxy Beta-Methylbutyrate)

Evidence Level
Moderate
2 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

Beta-hydroxy beta-methylbutyrate (HMB) is a metabolite of the essential amino acid leucine — produced when leucine is oxidized via the KIC (alpha-ketoisocaproate) pathway. As a downstream leucine metabolite, HMB is proposed to provide the anabolic and anti-catabolic signaling benefits of leucine at lower intakes, making it particularly valuable in populations experiencing muscle wasting (elderly, cancer cachexia, bed rest). The evidence for HMB in trained athletes is more mixed, with effects most pronounced in untrained individuals and clinical muscle-wasting conditions.

Studied Dose 3 g/day in divided doses (1 g three times daily); HMB-FA: 1–3 g/day pre-workout; clinical muscle wasting: 3 g/day; minimum 3–4 weeks for measurable effects
Active Compound HMB-Ca (calcium salt, most studied form) and HMB Free Acid (HMB-FA, faster absorption) — 3 g/day is the established clinical dose for both forms

Muscle mass preservation during inactivity and aging

The most robust clinical evidence for HMB is in muscle wasting conditions — bed rest, hospitalization, aging-related sarcopenia, and cancer cachexia. Multiple RCTs confirm HMB (3 g/day) significantly reduces muscle loss during immobilization and aging, with elderly populations showing the greatest benefit. HMB is included in some ICU nutrition protocols.

Strength and lean mass in untrained individuals

In untrained or recreationally active individuals beginning resistance training, HMB significantly accelerates strength gains and lean mass increases compared to training alone. Effect sizes are larger than in trained athletes, suggesting HMB is most beneficial during the early adaptation phase or after periods of detraining.

Exercise-induced muscle damage reduction

HMB reduces exercise-induced muscle damage markers (creatine kinase, lactate dehydrogenase) and reduces delayed onset muscle soreness (DOMS) following unaccustomed exercise. This anti-catabolic effect supports faster recovery between training sessions, particularly beneficial when training frequency is high or volume is suddenly increased.

Anti-catabolic effect via ubiquitin-proteasome inhibition

HMB reduces muscle protein breakdown by inhibiting the ubiquitin-proteasome pathway — the major intracellular protein degradation system activated during stress, immobilization, and aging. This anti-catabolic mechanism is distinct from and complementary to leucine's mTOR-mediated pro-anabolic effects.

1

mTORC1 activation and protein synthesis stimulation

HMB activates mTORC1 signaling — the master regulator of muscle protein synthesis — through mechanisms partially independent of leucine's direct mTOR activation. HMB activates the PI3K/Akt pathway upstream of mTOR, stimulating ribosomal S6 kinase 1 (S6K1) and 4E-BP1 phosphorylation to initiate muscle protein synthesis.

2

Ubiquitin-proteasome pathway inhibition

HMB downregulates expression of ubiquitin ligases (MuRF1, MAFbx/atrogin-1) that tag muscle proteins for proteasomal degradation. By reducing this catabolic pathway, HMB preserves existing muscle protein during catabolic conditions — explaining the anti-wasting effects in immobilization, aging, and disease states that are more consistent than the anabolic effects in healthy trained athletes.

3

Cholesterol synthesis and membrane integrity

HMB is a precursor in the mevalonate pathway — contributing to cholesterol synthesis required for cell membrane maintenance and repair. Rapidly dividing or repairing cells (including muscle satellite cells after exercise) require adequate membrane cholesterol; HMB provides substrate for membrane repair following exercise-induced damage.

1
HMB and Muscle Mass During Bed Rest — RCT
PubMed

Randomized, double-blind, placebo-controlled trial of HMB-Ca (3 g/day) vs. placebo in 24 healthy older adults during 10 days of bed rest followed by 8 weeks of rehabilitation.

24 healthy older adults. 10-day bed rest + 8-week rehabilitation.

HMB significantly attenuated lean body mass loss during bed rest (-0.49 kg vs -2.05 kg placebo) and improved lean mass recovery during rehabilitation. Muscle function better preserved. Supports HMB for preventing muscle wasting during hospitalization or immobilization.

2
HMB and Muscle Damage Reduction — Meta-Analysis
PubMed

Meta-analysis of RCTs examining HMB supplementation on exercise-induced muscle damage markers and recovery.

Pooled data from multiple RCTs in various exercise populations.

HMB significantly reduced creatine kinase (exercise damage marker), reduced DOMS scores, and improved recovery of strength following eccentric exercise. Effects consistent across studies. More pronounced in untrained individuals than trained athletes.

Common Potential side effects

Excellent safety profile; one of the most studied sports supplements for safety
Mild GI effects (nausea, diarrhea) in small percentage at 3 g/day
No adverse effects on liver, kidney, or hormonal function in any clinical study

Important Drug interactions

Statin medications — HMB is in the cholesterol synthesis pathway; theoretical interaction but no clinical evidence of significance
No established pharmacokinetic drug interactions at standard supplemental dose (3 g/day)